DUSP6 overexpression prevented cisplatin-dependent induction of both ERCC1 and XPF and restored sensitivity to cisplatin, confirming that DUSP6 has an antitumoural role in melanoma [138]. The gene discussed is DUSP6; the disease is melanoma.